These results provide convincing evidence for the pathogenicity of all seven variants that lead to complete deletion of exon 3, and suggest that other variants that result in complete loss of exon 3 at the molecular level will be associated with a high risk of cancer comparable to other classical pathogenic variants in BRCA2 (largely truncating), including c.316+2G>T. Here, BRCA2 is linked to cancer.